Evolent Health, Inc. (EVH)
- Previous Close
28.11 - Open
28.25 - Bid 33.02 x 800
- Ask 33.20 x 1400
- Day's Range
27.89 - 33.47 - 52 Week Range
17.98 - 35.00 - Volume
10,664,097 - Avg. Volume
2,256,288 - Market Cap (intraday)
3.804B - Beta (5Y Monthly) 1.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.94 - Earnings Date Oct 31, 2024 - Nov 4, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
40.15
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
www.evolent.com4,700
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: EVH
View MorePerformance Overview: EVH
Trailing total returns as of 8/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EVH
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EVH
View MoreValuation Measures
Market Cap
3.27B
Enterprise Value
3.80B
Trailing P/E
--
Forward P/E
19.27
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.36
Price/Book (mrq)
3.10
Enterprise Value/Revenue
1.62
Enterprise Value/EBITDA
57.69
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.16%
Return on Assets (ttm)
1.00%
Return on Equity (ttm)
-5.94%
Revenue (ttm)
2.35B
Net Income Avi to Common (ttm)
-106.2M
Diluted EPS (ttm)
-0.94
Balance Sheet and Cash Flow
Total Cash (mrq)
101.25M
Total Debt/Equity (mrq)
51.35%
Levered Free Cash Flow (ttm)
112.06M